Regulatory Record: Aeroflex Industria de Aerosol Ltda.

FDA action counts

Enforcement history

On 2026-05-22, Argus HQ recorded an FDA Warning Letter for Aeroflex Industria de Aerosol Ltda., rated "high" severity in Argus HQ's classification: Aeroflex Industria de Aerosol Ltda. — Refusal to Provide Access to and Copying of Records (2026-05-22). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Aeroflex Industria de Aerosol Ltda. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

Is this FDA enforcement data for Aeroflex Industria de Aerosol Ltda. official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Aeroflex Industria de Aerosol Ltda. had?

Argus HQ has recorded 1 FDA events for Aeroflex Industria de Aerosol Ltda.: 1 warning letters, 0 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Aeroflex Industria de Aerosol Ltda.?

The most recent FDA event Argus HQ has on file for Aeroflex Industria de Aerosol Ltda. is dated 2026-05-22, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Aeroflex Industria de Aerosol Ltda. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Aeroflex Industria de Aerosol Ltda. is observed, this page's event count and history update automatically.

Related enforcement actions

• Aeroflex Industria de Aerosol Ltda. — Refusal to Provide Access to and Copying of Records (2026-05-22) →

Compare with

• Aeroflex Industria de Aerosol Ltda. vs Philips North America
• Aeroflex Industria de Aerosol Ltda. vs Medline Industries, LP
• Aeroflex Industria de Aerosol Ltda. vs Boston Scientific Corporation
• Aeroflex Industria de Aerosol Ltda. vs Baxter Healthcare Corporation
• Aeroflex Industria de Aerosol Ltda. vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.